Efficacy of Transcranial Magnetic Stimulation in children with Autism Spectrum Disorder
- Conditions
- Health Condition 1: F840- Autistic disorder
- Registration Number
- CTRI/2019/02/017568
- Lead Sponsor
- Vishal Sondhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
(a) Indian Scale for Assessment of Autism Scores 70 or more
(b) Either parent should be willing and capable of following instructions and maintaining activity log
(a)History of seizure(s) in child or immediate (1st degree relative) family
(b)Abnormal EEG
(c)Secondary autism (as a co-morbidity of structural brain lesion, metabolic cause etc)
(d) Children with concomitant chronic systemic illnesses that can interfere with administration of intervention
(e)Children with any acute illness
(f)Children with history of fainting spells
(g) Children with metallic implants, pacemaker, VP shunt, Vagal Nerve Stimulator, Deep Brain Stimulator
(h) Dysmorphism involving head
(i)History of severe head injury
(j)Progressive neurological illness
(k)Children on medicines that decrease seizure threshold (eg. Baclofen)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare 6-16-year-old children and adolescents with Autism Spectrum Disorder (ASD) (Indian Scale for Assessment of Autismâ?¥ 70) managed with repetitive Transcranial Magnetic Stimulation (rTMS) once a week for twelve weeks with those managed with identical dosage of placebo, for change in Childhood Autism Rating Scale-2 (CARS-2) scores at 12 weeks of completion of interventionTimepoint: At 12 weeks of completion of intervention
- Secondary Outcome Measures
Name Time Method